Corrigendum to “Amiodarone induces cell proliferation and myofibroblast differentiation via ERK1/2 and p38 MAPK signaling in fibroblasts” [Biomed. Pharmacother. 115 (2019) 108889] - 18/09/19

Jie Weng ^a, 1

  Equal contributors.

, Mengyun Tu ^b, 1

  Equal contributors.

, Peng Wang ^a, Xiaoming Zhou ^a, Chuanyi Wang ^c, Xinlong Wan ^d, Zhiliang Zhou ^a, Liang Wang ^e, Xiaoqun Zheng ^b, Junjian Li ^f, Chan Chen ^{c, ⁎} , Zhiyi Wang ^{a, d, ⁎} , Zhibin Wang ^{d, ⁎}

^a Department of Emergency Medicine and General Practice, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, 325027, China 

^b Department of Medical Laboratory, The Second Affiliated Hospital of Wenzhou Medical College, Wenzhou, 325027, China 

^c Department of Geriatric Medicine, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325000, China 

^d Institute of Bioscaffold Transplantation and Immunology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, 325035, China 

^e Department of Biostatistics and Epidemiology, College of Public Health, East Tennessee State University, Johnson City, TN, USA 

^f Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China 

^⁎Corresponding author at: Institute of Bioscaffold Transplantation and Immunology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, 325035, China.Institute of Bioscaffold Transplantation and ImmunologySchool of Basic Medical SciencesWenzhou Medical UniversityWenzhou325035China^⁎⁎Corresponding authors.

Le texte complet de cet article est disponible en PDF.